Drawing for SK

USPTO serial 78738005

SK

Reviewed by CopyMark Law Group

Reg. 3411705Status 710
Filing date
Status date
Registration date
Apr 15, 2008
Examiner
CHOSID, ROBIN S
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles R Halloran

Charles R Halloran Kauth, Pomeroy, Peck & Bailey LLP2400 E. Katella AvenueSuite 1050Anaheim, CA 92806

Goods and services

ClassDescriptionStatusFirst use
005Baby foods made from agricultural products; baby food made from livestock products; lacteal flour for babies; baby food made from marine products; medicines for veterinary purposes, namely, for the treatment of gastrointestinal diseases; medicines for sensory organs, namely, central nervous system stimulants; repellents for dogs, preparations for destroying dry rot fungus, oral contraceptive pills, gummed medical taffeta plasters; slug exterminating preparations; mouthwashes for medical purposes; breath refreshers for medical purposes; vermifuges; Goulard water for use as an astringent or anti-inflammatory lotion; bronchodilating preparations; antiparasitic preparations; eye-wash; tobacco-free cigarettes for medical purposes; cod liver oil; agents affecting metabolism; liniments; poisons, namely, rat poison; chilblain preparations, digitalin; synthetic narcotics; anesthetics; agents affecting peripheral nervous system; anti-horse-fly oils; agents for immunity adjustment; mosquito-repellent incenses; agents for treating physically caused lesions; chemical preparations to treat wheat smut; remedies for perspiration; antiseptics; insect repellents; insect repellent incense; evacuants; chemical preparations to destroy mildew; vaccines, medicines for alleviating constipation; oriental medicines for women's diseases, namely, hormonal imbalances or fertility treatments; pharmaceutical preparations for treating dandruff; deodorants other than for personal use, namely, room deodorant, car deodorant, vitamin preparations, preparations of trace elements for human and animal use; germicides; acaricides; algicides; pesticides; insecticides, preparations for destroying noxious animals; biological preparations for medical purposes; bouillons for bacteriological cultures for medical or veterinary purposes; cellular function activating agents; anti-inflammatory agents; agents affecting digestive organs; styptic preparations; mercurial ointments for the treatment of burns; greases for veterinary purposes; amino acids for veterinary purposes; enzymes for veterinary purposes; enzyme preparations for veterinary purposes; cardiovascular agents; smelling salts; steroids, strychnine; poultices; nervines, aconitine; opiates; agents for ophthalmic use; antiallergic agents; mugwort for medical purposes; sulphonamides medicines; medicated candy; capsules for medicines, namely, Unit dose capsules sold empty for pharmaceutical use; jalap for use as a purgative; medicinal hair growth preparations; pills for dizziness symptoms treatment; pharmaceutical preparations, namely, elixirs for cough suppression; pills for inflammation treatment; opodeldoc, laxatives; tablets for menstruation circulation adjustment; disinfectants for hygiene purposes; medicines for protection against milk fever; larvae exterminating preparations; gases for medical purposes; leeches for medical purposes; gurjun balsam for medical purposes, siccatives for medical purposes; plasters for medical purposes; hydrogen peroxide for medical purposes; greases for medical purposes; glycerin for medical purposes; quinquina for medical purposes; sodium salts for medical purposes; medicated Jujube; rhubarb roots for pharmaceutical purposes; radio-isotope markers for therapeutic or diagnostic use; diastase for medical purposes; dill oil for medical purposes; lecithin for use as a dietary supplement; bacterial preparations for medical and veterinary use, chemical reagents for medical or veterinary purposes, petroleum jelly for medical purposes, balsamic preparations for medical purposes, radiological contrast substances for medical purposes; radioactive substance for medical purposes; adjuvants for medical purposes, namely, adjuvants for use with vaccines; additives to fodder for medical purposes; sarsaparilla for medical purposes; appetite suppressants for medical purposes; dietetic substances adapted for medical use, amino acids for medical purposes, Irish moss for intestinal disorders; albuminous preparations for medical purposes; alkaloids for medical purposes; rubbing alcohol, isopropyl alcohol for pharmaceutical purposes, namely, to treat wounds, angostura bark for medical purposes; smoking herbs for medical purposes, salts for medical purposes, namely, smelling salts, medicated bath salts, Epsom salt; Nutritional additives for use in foods and dietary supplements for human consumption; camphor and camphor oil for medical purposes, namely, as an ingredient in preparations to relieve pain and itching; gelatin for medical purposes, namely, gelatin capsules sold empty for pharmaceuticals; diagnostic preparations for medical purposes; herbal teas for medicinal purposes; chewing gum for medical purposes, namely, medicated chewing gum; potassium salts for medical purposes; tinctures for medical purposes; castor oil for medical purposes; herbs teas for medical purposes; blood for medical purposes; hormones for medical purposes; fennel for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; fumigation preparations for medical purposes; liquorice for pharmaceutical purposes, gentian for pharmaceutical purposes; guaiacol for pharmaceutical purposes; frostbite salve for pharmaceutical purposes; lupulin for pharmaceutical purposes; magnesia for pharmaceutical purposes, ergot for pharmaceutical purposes; malt for pharmaceutical purposes; mangrove bark for medical purposes; Melissa water for pharmaceutical purposes; charcoal for pharmaceutical purposes, namely, for gastrointestinal relief; gallic acid for pharmaceutical purposes, namely, for use as a preservative; myrobalan bark for pharmaceutical purposes; gentian; caustics for pharmaceutical purposes; bromine for pharmaceutical purposes, bismuth subnitrate for pharmaceutical purposes, bismuth preparations for pharmaceutical purposes, digestives for pharmaceutical purposes, hydrated chloral for pharmaceutical purposes, syrups for pharmaceutical purposes namely, cough syrup; linseed for pharmaceutical purposes, namely, for use in anti-itch creams; milk of almonds for pharmaceutical purposes, namely, for use as a nutritional supplement; aldehydes for pharmaceutical purposes; alcohol for pharmaceutical purposes, namely, for topical use; medicinal herbs in dried or preserved form; fishmeal for pharmaceutical purposes, esters for pharmaceutical purposes, ethers for pharmaceutical purposes; medicinal oils, iodine for pharmaceutical purposes; iodides for pharmaceutical purposes; alkaline iodides for pharmaceutical purposes; milk ferments for pharmaceutical purposes; eucalyptol for pharmaceutical purposes; eucalyptus for pharmaceutical purposes; flowers of sulphur for pharmaceutical purposes; decoctions for pharmaceutical purposes, namely, for the treatment of headaches; bicarbonate of soda for pharmaceutical purposes, aluminum acetate for pharmaceutical purposes; acetates for pharmaceutical purposes; medicinal infusions; cachou for pharmaceutical purposes; collodion for pharmaceutical purposes; creosote for pharmaceutical purposes; tartar for pharmaceutical purposes; turpentine for pharmaceutical purposes; oil of turpentine for pharmaceutical purposes, thymol for use as a fungicide or as an antiseptic; phenol for pharmaceutical purposes; pectin for pharmaceutical purposes; pepsins for pharmaceutical purposes; peptones for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; extracts of hops for pharmaceutical purposes, ferments for pharmaceutical purposes, medicinal alcohol, pills for tinnitus treatment, semen for artificial insemination; ginseng capsule; chemical preparations for the diagnosis of pregnancy; sticking plasters for medical use; herbicides; pyrethrum powder for extermininating insects; hematogen; pharmaceutical agents for tumor treatment; agents affecting central nervous system; agents for central nerve treatment; rat poison, radio-isotope markers for diagnostic use; diagnostic preparations for medical use; tranquillizers, analgesics; vaginal washes; asthmatic tea; medical preparations for slimming purposes; soporifics; radio-isotope markers for therapeutic use; preparations to facilitate teething; sea water for medicinal bathing; hemorrhoid preparations; powder of cantharides; cocaine; contact lens cleaning preparations; solutions for contact lenses; curare; corn remedies; fly destroying preparations; remedial agents for grape tree diseases; agents for elimination of grape root aphids; anti-uric preparations; anti-itch, anti-inflammation agents for anus; antibiotics; antibiotic preparations; anticryptogamic preparations; febrifuges; vermin destroying preparations; hemoglobin; hypoglycemic agents; blood solvent; blood plasma; agents for respiratory organs; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapy medicines; medicines for chemical obstacle treatment; chemical contraceptives; hydrastinine; hydrastine; reagents for measuring HBS antibody; musks for pharmaceutical purposes; headache pencils; anti-rheumatism rings; anti-rheumatism bracelets; chemical conductors for electrocardiograph electrodes; first-aid kits; hemostatic pencils; gauze; court plaster; bunion pads; sanitary pads; belts for sanitary napkins or towels; sanitary napkins; sanitary knickers; sanitary towels, menstruation tampons; antiseptic cotton; breast-nursing pads; napkins for incontinents; absorbent pants for incontinence; eye patches for medical purposes; pharmaceutical wafer; bone cement for surgical and orthopedic purposes; living tissue surgical implants; surgical dressings; vulnerary sponges; sanitary panties; medicated chewing gum; moleskin for medical purposes; oil and fat for medical purposes; adhesive bands for medical purposes; elastic bandages for medical purposes; porcelain for dental prostheses; ear bandages for medical purposes; rubber for dental purposes; dental lacquer; dental cements; dental amalgams; dental mastics; molding wax for dentists; dental veneers; absorbent cotton for medical purposes; fly glue; fly catching paper; mothproofing paper; nutritive substances for micro-organisms for medical use; antitumor agents; replacement meals for medical or pharmaceutical purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2014C8..CANCELLED SEC. 8 (6-YR)—
Aug 21, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 31, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 6, 2009CORVREVIEW OF CORRESPONDENCE COMPLETE—
Mar 11, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 25, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 23, 2009MAILPAPER RECEIVED—
Apr 15, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 7, 2008ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 8, 2008CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Dec 3, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2007FAXXFAX RECEIVED—
Nov 19, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 23, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 3, 2007NPUBNOTICE OF PUBLICATION—
Sep 14, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 10, 2007ALIEASSIGNED TO LIE—
Sep 7, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 6, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 6, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 6, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 1, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 18, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 10, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 10, 2007ALIEASSIGNED TO LIE—
Apr 4, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2007ALIEASSIGNED TO LIE—
Feb 6, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2006GNSLLETTER OF SUSPENSION E-MAILED—
Oct 25, 2006CNSLSUSPENSION LETTER WRITTEN—
Oct 4, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2006GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 14, 2006CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Apr 25, 2006DOCKASSIGNED TO EXAMINER—
Oct 25, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance